A MULTICENTER, RANDOMIZED, OPEN‑LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS FACTOR VIII PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A WITHOUT INHIBITORS (ZEBRHA-1)

Principal Investigator

Dr Susie Shapiro

Contact us

Email: christopher.deane@ouh.nhs.uk

IRAS number

1013205